Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.80% -0.05% 86.84M 56605.20
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.60% 1.42K% 3.690M Upgrade

Basic Info

Investment Strategy
The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.
General
Security Type Exchange-Traded Fund
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Category Index Russell Mid Cap Growth TR USD
Global Category Name US Equity Mid Cap
YCharts Categorization US Mid Cap
YCharts Benchmark Russell Midcap Total Return (^RMCTR)
Prospectus Objective Growth
Fund Owner Firm Name Innovator ETFs
Prospectus Benchmark Index
IBD 50 Index USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Anand Desai 6.37 yrs
Dustin Lewellyn 6.37 yrs
Ernesto Tong 6.37 yrs

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of April 26, 2024. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2017
2018
2019
2020
2021
2022
2023
YTD
37.62%
-16.76%
25.74%
18.20%
11.92%
-51.09%
12.40%
7.92%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
7.38%
--
--
20.59%
50.56%
22.69%
-22.60%
13.27%
3.29%
--
--
--
--
8.31%
-29.18%
13.75%
3.55%
--
--
--
--
--
-28.16%
17.95%
-1.01%
25.74%
-6.44%
26.66%
34.90%
21.17%
-24.06%
19.07%
6.00%
As of April 26, 2024.

Asset Allocation

As of April 25, 2024.
Type % Net % Long % Short
Cash 0.02% Upgrade Upgrade
Stock 99.98% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.
General
Security Type Exchange-Traded Fund
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Category Index Russell Mid Cap Growth TR USD
Global Category Name US Equity Mid Cap
YCharts Categorization US Mid Cap
YCharts Benchmark Russell Midcap Total Return (^RMCTR)
Prospectus Objective Growth
Fund Owner Firm Name Innovator ETFs
Prospectus Benchmark Index
IBD 50 Index USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Anand Desai 6.37 yrs
Dustin Lewellyn 6.37 yrs
Ernesto Tong 6.37 yrs

Top Portfolio Holders

0 of 0